Literature DB >> 3117692

Gamma interferon reverses inhibition of leukocyte bactericidal activity by a 25-kilodalton fraction from Mycobacterium tuberculosis.

A A Wadee1, J D Cohen, A R Rabson.   

Abstract

In this study we examined the effects of Mycobacterium tuberculosis cell extracts on the phagocytic activity of polymorphonuclear leukocytes and cultured peripheral blood monocytes. M. tuberculosis cell extracts were fractionated on Sephacryl S-200 columns, and a 25-kilodalton glycolipoprotein was shown to inhibit the intracellular killing ability of these leukocytes but had no effect on their phagocytic potential. This same fraction inhibited fusion of phagosomes with lysosomes, as assessed by noting the transfer of acridine orange from lysosomes to phagosomes. This fraction was shown to have a maximal inhibitory effect when it was in the form of an intact carbohydrate-lipid-protein complex. Gamma interferon (IFN-gamma), but not IFN-alpha, reversed the inhibitory effect of the mycobacterial component on bactericidal activity and on fusion of phagosomes and lysosomes. Thus, this 25-kilodalton fraction of M. tuberculosis cell extract may be important in protecting organisms against phagocytic degradation, an effect which can be reversed by IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117692      PMCID: PMC259976          DOI: 10.1128/iai.55.11.2777-2782.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Fluorescent markers for studying phagosome-lysosome fusion.

Authors:  M B Goren; C L Swendsen; J Fiscus; C Miranti
Journal:  J Leukoc Biol       Date:  1984-09       Impact factor: 4.962

2.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

Authors:  C D Rothermel; B Y Rubin; H W Murray
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line.

Authors:  C A Nacy; S L James; W R Benjamin; J J Farrar; W T Hockmeyer; M S Meltzer
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

4.  Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.

Authors:  C K Edwards; H B Hedegaard; A Zlotnik; P R Gangadharam; R B Johnston; M J Pabst
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

5.  Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence.

Authors:  Q N Myrvik; E S Leake; M J Wright
Journal:  Am Rev Respir Dis       Date:  1984-02

6.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.

Authors:  C Frehel; C de Chastellier; T Lang; N Rastogi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

9.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

Authors:  C F Nathan; T J Prendergast; M E Wiebe; E R Stanley; E Platzer; H G Remold; K Welte; B Y Rubin; H W Murray
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Bacterial endosymbiont-derived lipopolysaccharides and a protein on symbiosome membranes in newly infected amoebae and their roles in lysosome-symbiosome fusion.

Authors:  K J Kim; Y E Na; K W Jeon
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

3.  HLA expression in hepatocellular carcinoma cell lines.

Authors:  A A Wadee; A Paterson; K A Coplan; S G Reddy
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

4.  Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection.

Authors:  S Shalekoff; C T Tiemessen; C M Gray; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Effect of Aeromonas hydrophila enterotoxins on function of mouse phagocytes.

Authors:  G F Jin; C W Houston
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

7.  Isolation and partial characterization of glycolipid fractions from Mycobacterium avium serovar 2 (Mycobacterium paratuberculosis 18) that inhibit activated macrophages.

Authors:  M E Hines; J M Jaynes; S A Barker; J C Newton; F M Enright; T G Snider
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  A 25-kilodalton fraction from Mycobacterium tuberculosis that inhibits hexose monophosphate shunt activity, lysozyme release, and H2O2 production: reversal by gamma interferon.

Authors:  A A Wadee; A M Clara
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

9.  The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants.

Authors:  A A Wadee; R H Kuschke; T G Dooms
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.